Table 2.

Patterns of statin use and the proportion of patients in CVD risk groups

	Clinical ASCVD (n=330)	Other (n=710)	Non-Indicated (n=378)
Goal LDL (Ref)	<70	<100	-
Total LDL	108.96±36.21	129.27±37.27	122.24±30.16
Statin use	145 (43.9)	159 (22.4)	69 (18.3)
Non-statin use	185 (56.1)	551 (77.6)	309 (81.7)

ASCVD: history of myocardial infarction, coronary artery bypass grafting, percutaneous coronary intervention and stroke; Other: LDL-C ≥190 mg/l, diabetic or participants with Framingham Risk Score (FRS) ≥10%